lenalidomide has been researched along with Cerebral Cryptococcosis in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 2 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Guo, Y; Hang, Y; Hui, J; Liu, X; Peng, X; Tao, R; Wan, Z; Zhu, B; Zhu, X | 1 |
| Guo, Y; Huang, Y; Hui, J; Liu, X; Peng, X; Tao, R; Wan, Z; Zhu, B; Zhu, X | 1 |
2 other study(ies) available for lenalidomide and Cerebral Cryptococcosis
| Article | Year |
|---|---|
Lenalidomide potentially reduced the level of cell- associated HIV RNA and improved persistent inflammation in patients with HIV-associated cryptococcal meningitis a pilot study.
Topics: Cytokines; HIV Infections; HIV-1; Humans; Inflammation; Interleukin-6; Lenalidomide; Leukocytes, Mononuclear; Meningitis, Cryptococcal; Pilot Projects; RNA, Viral; Tumor Necrosis Factor-alpha | 2022 |
Efficacy and safety of lenalidomide in HIV-associated cryptococcal meningitis patients with persistent intracranial inflammation: an open-label, single-arm, prospective interventional study.
Topics: Albumins; HIV; HIV Infections; Humans; Inflammation; Lenalidomide; Meningitis, Cryptococcal; Prospective Studies | 2023 |